These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15885860)

  • 41. Myelodysplastic syndrome hematopoietic stem cell.
    Li J
    Int J Cancer; 2013 Aug; 133(3):525-33. PubMed ID: 23047726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?
    Song KW; Lipton J
    Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.
    Disperati P; Ichim CV; Tkachuk D; Chun K; Schuh AC; Wells RA
    Leuk Res; 2006 Feb; 30(2):233-9. PubMed ID: 16046234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. When to treat myelodysplastic syndromes.
    Akhtari M
    Oncology (Williston Park); 2011 May; 25(6):480-6. PubMed ID: 21717901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in myelodysplastic syndromes.
    Shadduck RK; Latsko JM; Rossetti JM; Haq B; Abdulhaq H
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):137-43. PubMed ID: 17379099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).
    Hasegawa D; Manabe A; Yagasaki H; Ohtsuka Y; Inoue M; Kikuchi A; Ohara A; Tsuchida M; Kojima S; Nakahata T;
    Pediatr Blood Cancer; 2009 Dec; 53(6):1011-5. PubMed ID: 19499580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Managing patients with low-risk MDS.
    Sekeres M; Cosgrove D; Falco A
    Clin Adv Hematol Oncol; 2006 Jul; 4(7 Suppl 16):1-10; quiz 11-2. PubMed ID: 17139240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
    Hosing C; Saliba RM; Shahjahan M; Estey EH; Couriel D; Giralt S; Andersson B; Champlin RE; De Lima M
    Bone Marrow Transplant; 2005 Jul; 36(2):157-62. PubMed ID: 15937511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
    Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
    Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
    Nolte F; Hofmann WK
    Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accelerated cellular senescence in myelodysplastic syndrome.
    Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
    Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelodysplastic syndromes in the United States: an update for clinicians.
    Troy JD; Atallah E; Geyer JT; Saber W
    Ann Med; 2014 Aug; 46(5):283-9. PubMed ID: 24716735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
    Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
    Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.